buserelin has been researched along with Cystadenocarcinoma, Serous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashijima, T; Kataoka, A; Motomura, S; Nishida, T; Sugiyama, T; Ueyama, T; Yakushiji, M | 1 |
1 other study(ies) available for buserelin and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
[The effects of sex steroid hormones, gonadotropins, and gonadotropin releasing hormone agonist on the proliferation of ovarian cancer cell line (KOC-2S)].
Topics: Buserelin; Cell Division; Cystadenocarcinoma, Serous; Estradiol; Female; Genes, erbB; Gonadotropins; Humans; Ovarian Neoplasms; Progesterone; Tumor Cells, Cultured | 1994 |